Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

7:06 AM ET 8-K
Financial Results Criteo S.A. CRTO

Criteo Financial Results

Criteo S.A. reported third quarter 2026 financial results with revenue of $416 million and net income of $6 million. The company highlighted the expansion of its Performance Connected TV capabilities into global markets and its ongoing advertising technology partnership with OpenAI.

“Despite near-term headwinds, we are making tangible progress across our business, with momentum in newer channels and a growing pipeline of opportunities. As we sharpen execution and operate with greater discipline, we remain focused on capturing the opportunities ahead and creating sustainable value for our shareholders.”

Michael Komasinski, Chief Executive Officer of Criteo
7:05 AM ET 8-K
Financial Results Seres Therapeutics, Inc. MCRB

Seres Therapeutics Financial Results

Seres Therapeutics reported Q3 2026 financial results and announced plans to advance SER-155 into a study for the prevention of immune checkpoint inhibitor-related enterocolitis (irEC). The company expects to submit the study design to the FDA in Q1 2027 following positive investigator-sponsored trial results showing an 80% clinical response rate.

Term
Q3 2026

“The irEC IST provided promising evidence that orally administered SER-155 improved epithelial barrier integrity and reduced gastrointestinal inflammation without systemic immunosuppression and was well-tolerated in patients with ICI-induced enterocolitis.”

Richard Kender, Executive Chairman and Interim Chief Executive Officer of Seres

“We believe SER-155 may enable ICI patients, of whom there are currently estimated to be approximately 300,000 in the U.S. alone, to remain on their therapy by reducing the occurrence of irEC, which often requires the halting of life-saving cancer treatment.”

Richard Kender, Executive Chairman and Interim Chief Executive Officer of Seres
7:05 AM ET 10-Q
Financial Results Brinks Co BCO ▶ Call

Brinks Q3 2027 Results

For the nine months ended September 30, 2026, Brink's reported revenues of $4,142.0 million, a 6.7% increase over the prior year, though net income attributable to the company decreased from $131.6 million to $91.0 million. The company experienced higher operating costs and a significant $62.4 million cash derecognition following the deconsolidation of its Malaysia business.

7:05 AM ET 8-K
Financial Results Charles River Laboratories International, Inc. CRL

Charles River Laboratories International Financial Results

Charles River Laboratories reported Q3 2026 revenue of $982.7 million and organic revenue growth of 4.7%, marking its second consecutive quarter of organic growth. The company increased its full-year 2026 guidance for both revenue and non-GAAP earnings per share, driven by outperformance in its Discovery and Safety Assessment (DSA) segment.

Term
Q3 2026

“Our third-quarter results were highlighted by a return to organic revenue growth for the second consecutive quarter and significant margin expansion, which drove non-GAAP earnings per share growth of 27%. We were pleased with the performance of our DSA and Manufacturing segments, which both delivered organic revenue growth and improved profitability.”

James C. Foster, Chairman, President and Chief Executive Officer
7:05 AM ET 8-K
Financial Results Wayfair Inc. W

Wayfair Financial Results

Wayfair reported third quarter 2026 net revenue of $3.4 billion, a 9.7% increase year-over-year, driven by 11.4% growth in its U.S. business. The company achieved net income of $62 million and grew its active customer base by 4.7% to 22.2 million, signaling structural market share gains in a flat category.

Term
Q3 2026

“Q3 was our strongest quarter of growth in the post-pandemic period, with total net revenue up 9.7% year-over-year and our U.S. business growing over 11%. That growth flowed through nicely to the bottom line, with an Adjusted EBITDA Margin of 6.9%, our best Q3 result since 2020.”

Niraj Shah, CEO, co-founder and co-chairman, Wayfair

“At the start of this year, we told you we expected to take share in the U.S. at a pace we had not seen in several years. With U.S. revenue growing double digits against a roughly flat category here in Q3, we've done exactly that. That growth was driven by orders, which were up 12% year-over-year, and active customers up more than 4%. The momentum we have on orders and customers give us confidence that our share gains are structural, and we are still in the early innings.”

Niraj Shah, CEO, co-founder and co-chairman, Wayfair
7:05 AM ET 8-K
Financial Results Trimble Inc. TRMB

Trimble Financial Results

Trimble Inc. reported third quarter 2026 revenue of $966.8 million, up 7% year-over-year, and record annualized recurring revenue (ARR) of $2.56 billion. The company exceeded expectations for the quarter and updated its full-year 2026 guidance, reflecting solid execution of its Connect & Scale strategy.

Term
Q3 2026

“Our third quarter results surpassed expectations on both revenue and earnings per share, while delivering record annualized recurring revenue of $2.56 billion. Our full year 2026 guidance reflects solid execution against our Connect & Scale strategy, which continues to leverage our unique presence across the physical and digital worlds with our unmatched breadth and depth of connected industry data.”

Rob Painter, President and CEO of Trimble
7:05 AM ET 8-K
Financial Results Solaredge Technologies, Inc. SEDG

Solaredge Technologies Financial Results

SolarEdge Technologies reported Q3 2026 revenue of $326.1 million, meeting the midpoint of its guidance despite a 4.1% year-over-year decline. The company achieved its fifth consecutive quarter of positive free cash flow at $7.8 million and is implementing cost-reduction measures to address softer demand and reduced Q4 expectations.

Term
Q3 2026

“The SolarEdge team delivered third-quarter revenue of $326.1 million, at the midpoint of our guidance, with profitability in line with expectations. As near-term market uncertainty persists and given reduced revenue expectations for the fourth quarter, we are taking decisive steps to reduce costs, sharpen our focus, and support profitability amid softer demand.”

Shuki Nir, CEO of SolarEdge
7:04 AM ET 8-K
Financial Results Q32 Bio Inc. QTTB

Q32 Bio Financial Results

Q32 Bio reported third quarter 2026 financial results and provided a corporate update, including clinical data from its SIGNAL-AA trial of bempikibart. The company ended the quarter with $289.6 million in cash, which is expected to fund operations through Phase 3 topline results. Management plans to initiate a registration-directed program for bempikibart in severe alopecia areata in the first half of 2027.

Term
Q3 2026

“The third quarter brought continued momentum for Q32 Bio and our bempikibart program. We shared encouraging SIGNAL-AA Part B results in late-breaking oral and poster presentations at EADV, highlighting bempikibart’s clinically meaningful efficacy data at Week 36 and ability to induce durable responses that were maintained or deepened through the 16-week off-drug period, supporting the potential for less frequent, chronic maintenance dosing”

Jodie Morrison, Chief Executive Officer of Q32 Bio

“We believe our data demonstrates the potential for bempikibart to become a first-line standard of care option for patients with alopecia areata. We are pleased to welcome José and Ellie to lead the advancement of bempikibart into late-stage development and have made key senior appointments spanning clinical operations, clinical strategy and medical affairs, and regulatory affairs.”

Jodie Morrison, Chief Executive Officer of Q32 Bio
7:04 AM ET 10-Q
Financial Results Option Care Health, Inc. OPCH

Option Care Health Q3 2026 Results: Net Income $57.4M, Up 10.8% YoY

Option Care Health reported net revenue of $1.49 billion for the third quarter of 2026, a 4.1% increase over the prior year, with net income rising to $57.4 million. The company significantly improved its operating cash flow to $286.2 million for the first nine months of 2026, while continuing to execute its share repurchase program, spending $170.5 million on treasury stock.

Key figure
Net income $57.4M · +10.8% YoY
7:04 AM ET 8-K
Financial Results New York Times Co NYT

New York Times Financial Results

The New York Times Company reported third-quarter 2026 results, highlighted by a 14.6% increase in digital-only subscription revenues and the addition of 420,000 net digital-only subscribers. Total revenues rose 9.7% to $768.5 million, while adjusted operating profit grew 13.9% to $149.6 million, reflecting strong marketer demand and subscriber retention.

Term
Q3 2026

“Q3 was another quarter of strong execution and sustained momentum across The Times. Our results highlighted the enduring advantages of our strategy and our multi-revenue stream model. Subscriber growth was powered by strong engagement and retention across our portfolio. We grew operating profit and generated healthy free cash flow while continuing to invest in growth areas like video. As the information ecosystem continues to evolve, our essential subscription strategy — which is about human-made journalism and product experiences that people seek out directly and make room for in their lives — provides powerful advantages that we believe will only deepen with time.”

Meredith Kopit Levien, president and chief executive officer, The New York Times Company
7:03 AM ET 8-K
Financial Results Biocryst Pharmaceuticals Inc BCRX

Biocryst Pharmaceuticals Financial Results

BioCryst reported Q3 2026 total net revenue of $180.3 million, driven by $174.8 million in ORLADEYO sales, and achieved an operating profit of $53.3 million. The company increased its full-year total revenue guidance to $715-$730 million and highlighted the recent FDA approval of ORLADEYO oral pellets for patients aged 12 and older.

Term
3 years

“In the third quarter, we delivered continued growth of ORLADEYO and strong profitability while broadening the foundation for our long-term success.”

Charlie Gayer, President and Chief Executive Officer

“This progress across our business increases our confidence in our ability to drive sustainable growth and lasting value for patients and shareholders.”

Charlie Gayer, President and Chief Executive Officer
7:03 AM ET 8-K
Financial Results SharkNinja, Inc. SN

SharkNinja Financial Results

SharkNinja reported third quarter 2026 net sales of $1.98 billion, a 21.2% increase year-over-year, driven by strong performance in Cooking and Beverage Appliances and International markets. Net income rose 79.3% to $338.4 million, and the company raised its full-year 2026 outlook based on strong operational performance and innovation across its product categories.

Term
Q3 2026

“Q3 net sales grew 21.2%, marking our second consecutive quarter above 20% and our 14th consecutive quarter of double-digit growth. Our topline strength was well balanced across Domestic and International, with tremendous performance across channels, categories, and geographies. We believe this reflects our evolution into a Consumer Technology company operating at hyperscale, which shows up in what we make, how we market and sell, how fast we learn, and how far we reach.”

Mark Barrocas, Chief Executive Officer
7:03 AM ET 8-K
Financial Results Brinks Co BCO

Brinks Financial Results

The Brink's Company reported third-quarter 2026 results with revenue of $1.375 billion, up 3% year-over-year, driven by strong organic growth in ATM Managed Services (AMS) and Digital Retail Solutions (DRS). The company also provided an update on its pending acquisition of NCR Atleos, which is now expected to close in early January 2027 following regulatory progress in the UK.

“We delivered a strong third quarter and continued to build real momentum in our strategic focus areas of AMS and DRS. Growth in these lines of business accelerated sequentially, even against a challenging economic backdrop in many of our larger markets. Adjusted EBITDA grew 8%, and margins expanded by 90 basis points year-over-year, powered by favorable revenue mix and strong pricing dynamics.”

Mark Eubanks, President and CEO

“We are making strong progress toward closing our acquisition of NCR Atleos. With increasing clarity and momentum on the regulatory front, including the recent developments with the CMA in the United Kingdom, we now expect to close the acquisition in early January 2027.”

Mark Eubanks, President and CEO
7:03 AM ET 8-K
Leadership Change Kraft Heinz Co KHC

Kraft Heinz Leadership Change

The Kraft Heinz Company appointed Kelly M. Dilts and J. Michael Schlotman to its Board of Directors, effective November 4, 2026. Ms. Dilts currently serves as CFO of Nordstrom, and Mr. Schlotman is the former CFO of The Kroger Co. The appointments add deep retail, grocery, and financial expertise to the board as the company continues its transformation strategy.

7:03 AM ET 8-K
Financial Results Cushman & Wakefield Ltd. CWK

Cushman & Wakefield Financial Results

Cushman & Wakefield reported third quarter 2026 revenue of $2.81 billion, an 8% increase year-over-year, driven by strong growth in leasing and capital markets. Adjusted EPS rose 28% to $0.37, while the company reaffirmed its full-year 2026 adjusted EPS growth guidance of 18% to 23%.

Term
Q3 2026

“Today we reported our seventh consecutive quarter of double-digit adjusted earnings per share growth, showcasing the power of our balanced platform and strategy. With $800 million in debt paydowns since 2024 our balance sheet has been transformed, and we enter this next stage of growth with increased strength, stability and optionality.”

Michelle MacKay, Chief Executive Officer of Cushman & Wakefield

“In three years, we have built a more agile and future-ready company, and the opportunity in front of us has never been greater. Our teams have consistently delivered, and we will continue to focus on converting the strength we have built into durable, profitable long-term growth.”

Michelle MacKay, Chief Executive Officer of Cushman & Wakefield
7:02 AM ET 8-K
Financial Results Marriott Vacations Worldwide Corp VAC

Marriott Vacations Worldwide Financial Results

Marriott Vacations Worldwide reported Q3 2026 financial results with contract sales increasing 29% year-over-year to $565 million and Adjusted EBITDA growing 27% to $216 million. The company raised its full-year guidance for contract sales and Adjusted EBITDA despite an estimated $16 million negative impact from Hurricane Lowell.

Term
Q3 2026

“We are very pleased with our third quarter financial results, as they demonstrate the substantive momentum in our business, on the heels of our strong second quarter. Further, they reflect the continued success of the strategies we began implementing in the second quarter as part of the transformation now underway. By way of example, VPG increased to an industry leading $4,822, 30% above last year, and our operating discipline drove 27% Adjusted EBITDA growth.”

Matt Avril, Chief Executive Officer
7:02 AM ET 8-K
Clinical Trial Data Genprex, Inc. GNPX

Genprex Clinical Trial Data

Genprex announced new research identifying TROP2 expression as a potential predictive biomarker for response to its lead gene therapy candidate, Reqorsa, in non-small cell lung cancer (NSCLC). Data from preclinical models and patient biopsies showed that low TROP2 expression is associated with resistance to treatment, which could help the company select more applicable patients for future clinical trials.

7:02 AM ET 8-K
Financial Results Mcdonalds Corp MCD

Mcdonalds Financial Results

McDonald's Corporation reported third quarter 2026 financial results with global systemwide sales increasing 4% to over $38 billion. While U.S. comparable sales declined slightly by 0.2%, consolidated operating income grew 7% and diluted earnings per share rose 10% to $3.51.

Term
Q3 2026

“McDonald’s delivered another quarter of global growth, with solid performance across much of our international business. In the U.S., we're encouraged by improvement as the quarter progressed following our intervention on value. We’re focused on building from here, strengthening the business today and investing in the next chapter of growth.”

Chris Kempczinski, Chairman and CEO
7:02 AM ET 8-K
Product Launch D-Wave Quantum Inc. QBTS

D-Wave Quantum Product Launch

D-Wave Quantum announced performance enhancements to its Stride hybrid solver and launched a new three-course Applied Quantum Optimization learning path. The updated solver, available via the Leap quantum cloud service, demonstrated significant speed and quality improvements in benchmark testing for complex optimization problems like the traveling salesperson problem.

7:02 AM ET 8-K
Financial Results Insulet Corp PODD

Insulet Financial Results

Insulet reported Q3 2026 revenue of $842 million, a 19.2% increase year-over-year, driven by strong Omnipod sales in both U.S. and international markets. Alongside the earnings, the company announced a new $1 billion stock repurchase program authorized through 2028, with $400 million planned for the fourth quarter of 2026.

7:01 AM ET 8-K
Financial Results Martin Marietta Materials Inc MLM

Martin Marietta Materials Financial Results

Martin Marietta reported record third-quarter 2026 revenues of $2.37 billion, a 28% increase driven by the acquisition of Lhoist North America (LNA). While net earnings from continuing operations decreased 29% to $256 million due to inflationary pressures and acquisition-related costs, Adjusted EBITDA rose 21% to $808 million.

“Martin Marietta delivered record quarterly revenues of $2.37 billion and Adjusted EBITDA from continuing operations of $808 million, representing increases of 28% and 21%, respectively, over the prior year third quarter, as strong performance from recent acquisitions more than offset the effects of expanding inflationary pressures and a dynamic macroeconomic environment.”

Ward Nye, Chair, President and CEO
7:01 AM ET 8-K
Financial Results Kraft Heinz Co KHC

Kraft Heinz Financial Results

Kraft Heinz reported third-quarter 2026 results with net sales of $6.1 billion, a 2.0% decrease compared to the prior year. The company updated its full-year outlook, raising the low end of its Organic Net Sales guidance while reporting a 14.6% decrease in operating income to $0.9 billion.

Term
Q3 2026

“Our 2026 operating plan to turn around the U.S. business and accelerate growth internationally is on track. Relative to last year, our market share, sales, and volume trends are improving in every region. We are increasingly meeting consumers where they are, and giving them more reasons to choose our brands.”

Steve Cahillane, CEO of Kraft Heinz

“As we approach the end of the year, we are raising the low end of our Organic Net Sales outlook, reflecting the momentum we have built. That progress is supported by a strong balance sheet, which gives us the flexibility to keep investing in our brands and our people.”

Steve Cahillane, CEO of Kraft Heinz
7:01 AM ET 8-K
Financial Results CPI Card Group Inc. PMTS

CPI Card Group Financial Results

CPI Card Group reported record third quarter 2026 revenue of $158 million, a 15% increase year-over-year, driven by double-digit growth across all business segments. Net income rose 117% to $5 million, and the company raised its full-year 2026 guidance for revenue growth and free cash flow for the second consecutive quarter.

Term
Q3 2026

“The third quarter marked another quarter of strong revenue, Adjusted EBITDA and Free Cash Flow growth, while we continued to invest in the business to help our customers win. Double-digit growth across each of our segments, improved profitability and strong commercial wins demonstrate the progress we are making against our strategy. We are gaining share while executing on our growth strategy to expand our capabilities, diversify our business and create new avenues for long-term growth and shareholder value creation.”

John Lowe, President and Chief Executive Officer
7:01 AM ET 8-K
Financial Results Smith Douglas Homes Corp. SDHC

Smith Douglas Homes Financial Results

Smith Douglas Homes reported third quarter 2026 results with home closing revenue of $262.5 million and diluted EPS of $0.07. While home closings and net new orders increased, profitability was impacted by higher mortgage rates and affordability pressures, leading to a decrease in pretax income to $3.3 million compared to $17.2 million in the prior year period.

Term
Q3 2026

“We continued to execute with discipline during the third quarter despite increasingly challenging housing market conditions. Higher mortgage rates and affordability pressures have weighed on buyer demand and profitability, but our teams remain focused on things we can control with respect to managing costs, building efficiently, and maintaining a steady absorption pace.”

Greg Bennett, Chief Executive Officer and Vice Chairman

“Our land-light operating model, efficient construction cycle times, and conservative balance sheet provide us with the flexibility to manage through periods of weaker demand without compromising our long-term objectives.”

Russ Devendorf, Executive Vice President and Chief Financial Officer
7:01 AM ET 8-K
Financial Results Bruker Corp BRKR

Bruker Financial Results

Bruker Corp reported Q3 2026 revenue of $874.0 million, a 1.6% increase year-over-year, and a non-GAAP operating margin expansion of 400 basis points to 16.3%. Despite a GAAP diluted loss per share of $(0.81) due to non-cash goodwill impairment charges, non-GAAP diluted EPS grew 24.4% to $0.56. The company reconfirmed its full-year 2026 organic revenue growth and non-GAAP EPS guidance.

Term
Q3 2026

“Bruker drives significant advances in post-genomic drug discovery and disease biology research, from proteoforms to glycobiology, and from functional protein interactions to spatial biology. These deeper insights into molecular, cell and tissue biology are foundational for successful drug development and useful AI frontier models. Together with strong growth-drivers in infectious disease diagnostics, and in deep-tech and semiconductor metrology, we are poised for growth acceleration.”

Frank H. Laukien, Bruker’s President and CEO

“In the third quarter, we achieved very significant margin expansion and non-GAAP EPS growth, driven by our focus on cost discipline and execution. Bruker’s positive booking trends continued with the fifth consecutive quarter of Bruker Scientific Instruments (BSI) book-to-bill greater than one. We see strengthening demand in most of our end markets, and in Q3 also in the US academic market. With BSI organic bookings and backlog both up mid-single digits % year-to-date, we expect revenue growth acceleration, continued margin expansion and double-digit EPS growth in FY27.”

Frank H. Laukien, Bruker’s President and CEO
7:01 AM ET 8-K
Financial Results Advantage Solutions Inc. ADV

Advantage Solutions Financial Results

Advantage Solutions reported Q3 2026 revenue of $913.7 million and a net loss of $25.1 million, while announcing a restructuring plan expected to generate $25 million in annualized net savings. The company saw strong growth in its Experiential Services segment (+14.3%) but faced continued pressure in Branded Services, leading to a 14.2% decline in Adjusted EBITDA.

Term
Q3 2026

“We delivered our fourth consecutive quarter of revenue growth excluding divestitures, driven by continued strength in Experiential and Retailer Services, and we are reaffirming our full-year guidance. The restructuring announced today is expected to generate approximately $25 million in near-term annualized savings net of investment while improving the profitability of our Branded Services business and increasing efficiency across the company.”

Dave Peacock, Chief Executive Officer
7:01 AM ET 8-K
Financial Results Reynolds Consumer Products Inc. REYN

Reynolds Consumer Products Financial Results

Reynolds Consumer Products reported third quarter 2026 net revenues of $944 million, a slight increase from the prior year despite a 7% decline in retail volumes. The company achieved gross profit growth through pricing actions and productivity gains, which helped offset significant commodity inflation. Management reaffirmed its full-year 2026 outlook for revenue and Adjusted EBITDA.

Term
Q3 2026

“We delivered a solid third quarter in a volatile operating environment, acting decisively to address significant commodity inflation and delivering earnings in-line with our guidance. We made further progress on our productivity initiatives, allowing us to continue investing behind our brands, innovation and other strategic initiatives.”

Scott Huckins, President and Chief Executive Officer
7:00 AM ET 8-K
Financial Results OPENLANE, Inc. OPLN

OPENLANE Financial Results

OPENLANE reported Q3 2026 revenue of $561 million, a 13% year-over-year increase, driven by strong growth in marketplace commercial and dealer vehicles sold. The company also announced that its board authorized a $150 million increase to its share repurchase program, bringing the total authorization to $400 million through 2027.

Term
Q3 2026

“The positive momentum OPENLANE sustained in the third quarter reinforces the strength of our strategy and the differentiated value we deliver to the market. We grew consolidated revenue by 13%, delivered Adjusted EBITDA of $107 million and grew marketplace GMV by 38% to $10 billion. Our US dealer volumes grew 22%, meaningfully outpacing the industry, while our commercial business accelerated from the upward inflection of off-lease volumes. And we believe the recent changes to our competitive landscape provide OPENLANE with a unique opportunity to gain additional market share.”

Peter Kelly, CEO of OPENLANE

“OPENLANE’s focused execution continues to fuel growth and deliver compelling operational and financial results. We are successfully leveraging OPENLANE’s unique advantages with AFC’s independent dealers and the franchise dealers in our private label programs. We are extending our lead in technology, improving the customer experience and gaining in brand preference. And we remain well positioned to close out 2026 and enter the new year with strength and momentum.”

Brad Herring, CFO of OPENLANE
7:00 AM ET 8-K
Financial Results Odyssey Therapeutics, Inc. ODTX

Odyssey Therapeutics Financial Results

Odyssey Therapeutics reported third quarter 2026 financial results, ending the period with $387 million in cash and equivalents. The company highlighted clinical progress for its RIPK2 inhibitor OD-001 in ulcerative colitis and the completion of IND-enabling studies for its SLC15A4 inhibitor OD-002.

Term
Q3 2026

“Over the past several months, we have made meaningful progress across our entire pipeline, highlighted by additional analyses from the Phase 2a induction period for OD-001 demonstrating that clinical efficacy is supported by concordant biomarker and transcriptomic findings, further reinforcing previously established clinical proof of concept in patients with ulcerative colitis.”

Gary D. Glick, Ph.D., founder and chief executive officer of Odyssey Therapeutics

“We have also continued to advance the clinical development of OD-001 while completing IND-enabling studies for OD-002, our SLC15A4 inhibitor. Together with an enhanced executive leadership team and strong financial foundation, these achievements position us to execute on our clinical development strategy and drive continued progress throughout our portfolio.”

Gary D. Glick, Ph.D., founder and chief executive officer of Odyssey Therapeutics
7:00 AM ET 8-K
Financial Results Performance Food Group Co PFGC

Performance Food Group Financial Results

Performance Food Group reported first-quarter fiscal 2027 results with net sales increasing 5.5% to $18.0 billion and net income rising 38.4% to $129.5 million. The company saw strong case volume growth, particularly in the independent Foodservice channel which grew 7.8%, and reiterated its full-year fiscal 2027 financial guidance.

Term
Q1 2027

“We started fiscal 2027 with solid momentum, delivering strong first-quarter sales and profit growth. Continued market share gains across our businesses drove strong case volume and revenue performance in the quarter. Our team’s execution on several key efficiency initiatives improved our profitability, driving gross margin expansion and double-digit Adjusted EBITDA and EPS growth in the quarter. We recognize the macroeconomic environment remains challenging, but I am confident in our ability to continue gaining market share, execute our strategic priorities and deliver strong results through the remainder of fiscal 2027.”

Scott McPherson, PFG’s President and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.